Literature DB >> 28786967

Serum homocysteine levels in patients with probable vascular dementia.

Salem Alajbegović1, Orhan Lepara2, Almira Hadžović-Džuvo2, Alma Mutevelić-Turković2, Lejla Alajbegović3, Asija Zaćiragić2, Nesina Avdagić2, Amina Valjevac2, Nermina Babić2, Amela Dervišević2.   

Abstract

Aim To investigate total homocysteine (tHcy) serum concentration in patients with probable vascular dementia (VD) and in agematched controls, as well as to determine an association between tHcy serum concentration and cognitive impairment in patients with probable VD. Methods Serum concentration of tHcy was determined by the Fluorescence Polarization Immunoassay on the AxSYM System. Cognitive impairment was tested by the Mini Mental Status Examination (MMSE) score. Body mass index (BMI) was calculated for each subject included in the study. Results Age, systolic, diastolic blood pressure and BMI did not differ significantly between the two groups. Mean serum tHcy concentration in the control group of subjects was 13.35 µmol/L, while in patients with probable VD it was significantly higher, 19.45 µmol/L (p=0.002). A negative but insignificant association between serum tHcy concentration and cognitive impairment in patients with probable VD was found. Conclusion Increased tHcy concentration in patients with probable VD suggests the possible independent role of Hcy in the pathogenesis of VD. Copyright© by the Medical Assotiation of Zenica-Doboj Canton.

Entities:  

Keywords:  Mini-Mental State Examination; cognitive impairment; neurotoxicity

Mesh:

Substances:

Year:  2017        PMID: 28786967     DOI: 10.17392/916-17

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  3 in total

1.  Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients.

Authors:  Svetlana Tomic; Vlasta Pekic; Zeljka Popijac; Tomislav Pucic; Marta Petek Vinkovic; Tihana Gilman Kuric; Zvonimir Popovic
Journal:  Neurol Sci       Date:  2018-06-30       Impact factor: 3.307

2.  Diagnostic Values of Advanced Glycation End Products and Homocysteine in Patients with Alzheimer's Disease and Sarcopenia.

Authors:  Xuelian Zhang; Yunxia Meng; Weiwei Zhang; Luhang Shi; Xia Liu; Lijuan Zhang; Qiaoling Liu
Journal:  Comput Math Methods Med       Date:  2022-09-09       Impact factor: 2.809

3.  S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.

Authors:  Hannah Maier; Saskia Helm; Sermin Toto; Nicole Moschny; Wolfgang Sperling; Thomas Hillemacher; Kai G Kahl; Ewgeni Jakubovski; Stefan Bleich; Helge Frieling; Alexandra Neyazi
Journal:  Dis Markers       Date:  2018-01-10       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.